Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Featured
Page 83
Featured
Featured posts
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
BridgeBio’s BEYONTTRA approved by European Commission to treat ATTR-CM
UK unveils funding for AI companies to transform cancer care and spark new drug breakthroughs
FDA approves cell therapy for patients with blood cancers to reduce...
18th April 2023
University of Oxford malaria vaccine receives regulatory clearance for use in...
18th April 2023
ECCMID 2023: Shionogi announces real-world evidence demonstrating the efficacy of Fetcroja®...
17th April 2023
SynaptixBio secures £13.2m to develop treatment for rare, incurable and deadly...
14th April 2023
Neuromod Devices closes €30m financing to expand availability of tinnitus treatment...
13th April 2023
Enanta Pharmaceuticals receives FDA Fast Track designation for respiratory syncytial virus...
12th April 2023
FDA moves forward with mail-back envelopes for opioid analgesics
12th April 2023
Female led UK biotech start-up secures £1.27m to revolutionise intracellular drug...
11th April 2023
GSK and SCYNEXIS enter into exclusive agreement to commercialise and further...
5th April 2023
BioNTech and DualityBio form global strategic partnership to accelerate development of...
5th April 2023
1
...
82
83
84
...
146
Page 83 of 146
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...